Skip to Content

Join the 'Urinary Incontinence' group to help and get support from people like you.

Urinary Incontinence News

Related terms: Bladder, Weak, Incontinence, Weak Bladder, Involuntary Urination, Urinary Tract Incontinence

Health Tip: Identifying Common Bladder Problems in Women

Posted 16 days ago by Drugs.com

-- Women may have a variety of bladder problems as they age. But many don't seek help because they are embarrassed or believe their symptoms are a normal part of aging. Womenshealth.gov identifies these women's symptoms that may indicate a bladder problem: Needing to go to the bathroom eight or more times per day. Getting up to go to the bathroom at night. Having a strong urge and fearing you might not make it to the bathroom in time. Unwanted loss of urine from your bladder (urinary incontinence). Read more

Related support groups: Bladder Infection, Overactive Bladder, Urinary Incontinence

Common Exercise Therapy May Not Help Women With Leaky Bladder

Posted 17 Oct 2017 by Drugs.com

MONDAY, Oct. 16, 2017 – A commonly promoted exercise purported to help a woman control a leaky bladder probably isn't effective, experts say. The workout – called the abdominal hypopressive technique – (AHT) is a breathing and "posture-correcting" approach widely known and used in North America, South America and Europe, said a team of European researchers. With AHT, patients breathe in deeply through the diaphragm, contract the abdominal muscles after fully breathing out, and hold their breath before relaxing. But the new review of available research on the technique yielded no proof that it helps urinary incontinence, researchers reported online Oct. 16 in the British Journal of Sports Medicine. Even though there's "a worldwide huge interest" in AHT among women, "at present, there is no scientific evidence to recommend its use to patients," said Kari Bo, of the Norwegian School of ... Read more

Related support groups: Overactive Bladder, Urinary Incontinence

Health Tip: Recognizing Prostate Cancer

Posted 29 Sep 2017 by Drugs.com

-- Prostate cancer is the most common form of cancer among men. And black men are more likely to get the disease, and twice as likely to die from it, the U.S. Food and Drug Administration says. The slow-growing disease often shows few or no symptoms until it's too late. But if symptoms do emerge, they may include: Difficulty beginning urination. Weak or interrupted flow of urine. Frequent urination, especially at night. Since these symptoms also may be related to other causes, such as an enlarged prostate, men who have these symptoms should see a doctor without delay, the FDA says. Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Urinary Incontinence, Prostate Cancer, Prostatitis, Prostate Tumor - Benign

Consider Acupuncture for Incontinence, But Not Infertility Due To PCOS

Posted 27 Jun 2017 by Drugs.com

TUESDAY, June 27, 2017 – Acupuncture, a 3,000-year-old healing technique, received mixed reviews in two new studies from China – one focusing on incontinence and the other on a cause of female infertility. A research team found acupuncture did improve symptoms of stress incontinence – an involuntarily loss of urine, such as when a woman sneezes or coughs. But in a separate study, another team of researchers determined that acupuncture did not help women who were infertile because of polycystic ovary syndrome (PCOS). Women with PCOS have a hormonal imbalance that keeps them from releasing an egg (ovulating) during the menstrual cycle. Acupuncture is a key element of traditional Chinese medicine. It involves inserting thin needles into the skin to stimulate specific body points. Previous research has found it might benefit constipation, depression and morning sickness, among other ... Read more

Related support groups: Menstrual Disorders, Polycystic Ovary Syndrome, Overactive Bladder, Urinary Incontinence, Premenstrual Dysphoric Disorder, Premenstrual Syndrome, Menorrhagia

Drug Tied to Dementia Risk Overprescribed to Seniors: Study

Posted 31 Mar 2017 by Drugs.com

THURSDAY, March 30, 2017 – A drug linked to a raised risk of dementia is taken by millions of older Americans who have an overactive bladder, researchers say. More than one-quarter of patients with the urinary problem had been prescribed the drug oxybutynin (Ditropan), an international team of investigators found. Yet, "oxybutynin is a particularly poor drug for overactive bladder in elderly patients," said study lead author Dr. Daniel Pucheril, a urologist at Henry Ford Hospital in Detroit. Prior studies have linked the drug to thinking problems and increased risk of dementia in older people, possibly because of the way it affects brain chemicals, he said. "It's a great and effective drug for younger patients, but is a risky drug for older patients," Pucheril said. It boosts dementia risk even when not taken indefinitely, he said. Alternatives exist but they're more expensive and may ... Read more

Related support groups: Dementia, Overactive Bladder, Urinary Incontinence, Alzheimer's Disease, Oxybutynin, Oxytrol, Mild Cognitive Impairment, Ditropan, Gelnique, Lewy Body Dementia, Ditropan XL, Urotrol, Anturol

Curbing Sleep Apnea Might Mean Fewer Night Trips to Bathroom

Posted 27 Mar 2017 by Drugs.com

MONDAY, March 27, 2017 – Millions of Americans battle bothersome nighttime conditions, such as sleep apnea or the need to get up frequently to urinate. Now, new research suggests that treating the former condition with CPAP "mask" therapy might also help ease the latter. "This is the first study to show the true incidence of nocturia – peeing at night – in patients who suffer from obstructive sleep apnea. It's also the first study to show the size of the effect of positive pressure mask treatment [CPAP] in patients with obstructive sleep apnea on their nocturia symptoms," said lead researcher Sajjad Rahnama'i, of Maastricht University Medical Center in the Netherlands. Rahnama'i presented his team's findings Sunday at the European Association of Urology (EAU) annual meeting in London. One U.S. apnea expert who reviewed the new findings said apnea and nighttime overactive bladder ... Read more

Related support groups: Overactive Bladder, Urinary Incontinence, Sleep Apnea, Obstructive Sleep Apnea/Hypopnea Syndrome, Primary Nocturnal Enuresis

Less Salt, Fewer Nighttime Bathroom Trips?

Posted 27 Mar 2017 by Drugs.com

SUNDAY, March 26, 2017 – Lowering your salt intake could mean fewer trips to the bathroom in the middle of the night, a new study suggests. Most people over age 60, and many even younger, wake up to pee one or more times a night. This is called nocturia. This interruption of sleep can lead to problems such as stress, irritability or tiredness, which can affect quality of life. There are several possible causes of nocturia, including – as this study found – the amount of salt in your diet. "This is the first study to measure how salt intake affects the frequency of going to the bathroom, so we need to confirm the work with larger studies," said study leader Tomohiro Matsuo, from Nagasaki University in Japan. "Nighttime urination is a real problem for many people, especially as they get older. This work holds out the possibility that a simply dietary modification might significantly ... Read more

Related support groups: Overactive Bladder, Urinary Incontinence, Primary Nocturnal Enuresis

Noctiva Approved for Frequent Urination at Night

Posted 6 Mar 2017 by Drugs.com

MONDAY, March 6, 2017 – Noctiva nasal spray has been approved by the U.S. Food and Drug Administration to treat frequent urination at night due to excess urine production. Norturia, the medical term for getting up at night to urinate, can be caused by factors such as congestive heart failure, diabetes, certain medications or diseases of the bladder or prostate, the agency said in a news release. Noctiva (desmopressin acetate) is approved for adults with nocturnal polyuria, an overproduction of urine at night. Noctiva is the first drug approved to treat the condition in the United States, the FDA added. Before prescribing Noctiva, health care providers should confirm overproduction of urine at night by collecting a 24-hour urine sample, the FDA recommended. They should also make sure a person's habits, such as excessive consumption of fluids, may not be contributing to the problem. ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Hypertension, Congestive Heart Failure, Heart Failure, Overactive Bladder, Urinary Incontinence, Pre-Diabetes, Left Ventricular Dysfunction, Diabetes Mellitus, Hypertensive Congestive Heart Failure, Hypertensive Heart Disease, Noctiva

New Nasal Spray, Noctiva, Reduces Nighttime Urination

Posted 6 Mar 2017 by Drugs.com

A nasal spray formulation of desmopressin acetate, effective at reducing the number of times adults have to urinate during the night, has been approved by the U.S. Food and Drug Administration. Noctiva (desmopressin acetate) is a nasal spray for adults who make at least two nighttime trips to the bathroom due to causes such as certain medications, chronic heart failure, poorly controlled diabetes, and bladder and prostate problems, the Associated Press reported. The spray, used about 30 minutes before bedtime each night, helps the kidneys absorb more water in order to reduce the amount of urine. Noctiva carries a black box warning – the FDA's strongest – about the risk of dangerously low levels of sodium in the blood. Other possible side effects include colds, bronchitis, a rise in blood pressure, dizziness, back pain and nose bleeds, the AP reported. The drug was developed by ... Read more

Related support groups: Diabetes, Type 2, Benign Prostatic Hyperplasia (BPH), Congestive Heart Failure, Heart Failure, Overactive Bladder, Urinary Incontinence, Prostatitis, Pre-Diabetes, Left Ventricular Dysfunction, Diabetes Mellitus, Prostate Tumor - Benign, Noctiva

Anxiety May Lead to Unneeded Prostate Cancer Treatments

Posted 27 Jan 2017 by Drugs.com

FRIDAY, Jan. 27, 2017 – Anxiety may prompt prostate cancer patients to opt for potentially unnecessary treatments, a new study suggests. The research included more than 1,500 men newly diagnosed with localized prostate cancer. They were more likely to choose surgery and radiation therapy than active surveillance. Active surveillance – also known as "watchful waiting" – is when the patient is monitored closely, but not treated. "Men's level of emotional distress shortly after diagnosis predicted greater likelihood of choosing surgery over active surveillance," said the researchers from the University at Buffalo and Roswell Park Cancer Institute in Buffalo, N.Y. "Importantly, this was true among men with low-risk disease, for whom active surveillance may be a clinically viable option and side effects of surgery might be avoided," they noted. Though the study found an association ... Read more

Related support groups: Anxiety, Anxiety and Stress, Erectile Dysfunction, Urinary Incontinence, Prostate Cancer, Genitourinary Surgical and Other Conditions

Staying Trim, Strong May Cut Risk of Urinary Incontinence

Posted 31 Dec 2016 by Drugs.com

FRIDAY, Dec. 30, 2016 – Urinary incontinence is a widespread complaint among women, but a new study suggests that older women may find relief from this frustrating problem if they're slimmer and stronger. The study followed nearly 1,500 women in their 70s for three years. Researchers found that a decrease in body mass index of 5 percent or more during that time led to a 50 percent reduction in the risk of new or persistent stress urinary incontinence. Body mass index (BMI) is a rough estimate of a person's body fat based on height and weight. For example, a woman who's 5 feet 6 inches tall who weighs 175 pounds has a BMI of 28.2. If she lost 5 percent of her BMI, it would be 26.8, which translates to a weight loss of about 9 pounds. The study also showed that a decrease in grip strength of 5 percent or more was linked to 60 percent higher odds of new or persistent stress urinary ... Read more

Related support groups: Overactive Bladder, Urinary Incontinence

New Prostate Cancer Therapy Works Without Severe Side Effects

Posted 21 Dec 2016 by Drugs.com

A new treatment for early stage Prostate Cancer is "transformative," according to researchers. The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported. A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment. Only six percent of those who had the treatment had to undergo prostate removal, compared with 30 percent who did not have the new therapy. Many prostate cancer patients who have surgery or radiation therapy have lifelong impotence and urinary incontinence. But sexual and urination problems lasted no longer than three months among patients who had the new therapy, according to the study in The Lancet Oncology. The drug used in the treatment is made from bacteria that live in near total darkness on the ... Read more

Related support groups: Cancer, Erectile Dysfunction, Urinary Incontinence, Prostate Cancer

Health Highlights: Dec. 20, 2016

Posted 20 Dec 2016 by Drugs.com

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: New Prostate Cancer Therapy Works Without Severe Side Effects A new treatment for early stage prostate cancer is "transformative," according to researchers. The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported. A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment. Only six percent of those who had the treatment had to undergo prostate removal, compared with 30 percent who did not have the new therapy. Many prostate cancer patients who have surgery or radiation therapy have lifelong impotence and urinary incontinence. But sexual and urination problems lasted no longer than three months among patients who ... Read more

Related support groups: Cancer, Breast Cancer, Urinary Incontinence, Prostate Cancer

Botox Beats Implant for Urinary Urgency Incontinence in Women

Posted 4 Oct 2016 by Drugs.com

TUESDAY, Oct. 4, 2016 – For women with bladder incontinence who haven't been helped by medications or other therapies, Botox injections may help control leakage better than an implanted nerve stimulation device, a new study suggests. However, both treatments are effective, according to doctors who treat the condition. In a head-to-head comparison, women given Botox saw their number of daily urgency incontinent episodes decrease by four, on average, compared to three for women who received the implant, called InterStim. Botox patients also said they had a greater reduction in symptoms and were more satisfied with the treatment, the researchers said. "Many women suffer from urgency incontinence and find inadequate relief of their problem from medications or behavioral changes," said lead researcher Dr. Cindy Amundsen. She's a professor of obstetrics and gynecology at Duke University in ... Read more

Related support groups: Overactive Bladder, Urinary Incontinence, Botox, Onabotulinumtoxina, Botox Cosmetic

FDA Medwatch Alert: Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results

Posted 16 Sep 2016 by Drugs.com

ISSUE: Virtus Pharmaceuticals Opco II, LLC (Virtus) is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg) to the consumer level which include the tablet, sublingual, and orally disintegrating tablet form. This recall is being initiated due to both superpotent and subpotent test results. All of these batches were manufactured by Pharmatech LLC for distribution by Virtus throughout the United States and Puerto Rico. See the press release for a listing of affected batch numbers. Taking a product that is superpotent could result in hot/dry skin, fever, blurred vision, sensitivity to light, dry mouth, unusual excitement, fast or irregular heartbeat, dizziness, an inability to completely empty the bladder, and seizures. The severity of the adverse event would depend on how superpotent the tablet was. Adverse events such as clotted blood within the tissues and fractures could ... Read more

Related support groups: Irritable Bowel Syndrome, Urinary Incontinence, Hyoscyamine, Levsin, Levsin SL, Symax Duotab, HyoMax, Anaspaz, Hyosyne, Symax FasTab, HyoMax SL, Hyosol, Symax FasTabs, HyoMax SR, Cystospaz, Spasdel, IB-Stat, Colidrops, Donnamar, Gastrosed

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Overactive Bladder, Voiding Disorders

Related Drug Support Groups

amitriptyline, Elavil, duloxetine, oxybutynin, Botox, VESIcare, Myrbetriq, hyoscyamine, cranberry, view more... Toviaz, Endep, Oxytrol, Enablex, Detrol, Ditropan, Sanctura, mirabegron, Levsin, Detrol LA, solifenacin, Gelnique, tolterodine, Levsin SL, trospium, Sanctura XR, Symax Duotab, HyoMax, Anaspaz, onabotulinumtoxina, Hyosyne, flavoxate, Ditropan XL, darifenacin, HyoMax SR, HyoMax SL, Symax FasTab, Hyosol, Gastrosed, Colidrops, HyoMax DT, HyoMax FT, Ed-Spaz, Hyospaz, NuLev, IB-Stat, Levsinex, fesoterodine, Urispas, Vanatrip, Urotrol, Regurin, Spasdel, A-Spaz, Donnamar, Levbid, Symax SR, Cystospaz, Cystospaz-M, Levsinex SR, Symax SL, A-Spas S / L, Oscimin